Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials.

Blood Cancer J · 2018 · PMC6224549 · PMID 30410035

Europe PMC DOI

hedged sentence

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

almost significantlyp = 0.059so close (0.05 < p ≤ 0.1)

In a subgroup analysis by the clinical prognostic index IPI, we can observe that IPI remained almost significantly predictive of survival (with patients with IPI score > 3 showing inferior OS, p = 0.059).

also in 555 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.